Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Albert Cha


  • Director at Kalvista Pharmaceuticals Inc. (KALV), 2019-10-03
  • Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), 2018-05-03
  • Director at Menlo Therapeutics Inc. (MNLO), 2018-01-29
  • Director at Aclaris Therapeutics Inc. (ACRS), 2016-07-01
  • Director at Pronai Therapeutics Inc (DNAI), 2015-07-21
  • Large Shareholder at Capnia Inc. (CAPN), 2014-11-21
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KALV $17.13 5,137 Director 124,566 2019-07-29 Filing
KALV $17.13 24,730 Director 1,022,493 2019-07-29 Filing
KALV $16.83 21,942 Director 997,763 2019-07-26 Filing
KALV $16.83 4,558 Director 119,429 2019-07-26 Filing
KALV $17.00 1,058,824 Director 1,359,149 2018-09-10 Filing